Lidocaine 1% injectable solution
( DrugBank: Lidocaine / KEGG DRUG: Lidocaine, Lidocaine hydrochloride, Lidocaine hydrochloride monohydrate )
2 diseases
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 34 | Neurofibromatosis | 1 |
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 168 | Ehlers-Danlos syndrome | 1 |
34. Neurofibromatosis
Clinical trials : 165 / Drugs : 189 - (DrugBank : 83) / Drug target genes : 93 - Drug target pathways : 209
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
168. Ehlers-Danlos syndrome
Clinical trials : 16 / Drugs : 22 - (DrugBank : 10) / Drug target genes : 11 - Drug target pathways : 103
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|